Sign in

CIK 0001816590

  • Non-accelerated filer
  • Smaller reporting company

COMPASS Pathways plc

Sign in to watch
Ticker
CMPS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 716-676-6461
Business address
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
Former names
Compass Rx Ltd.
  1. 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
  2. 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
  3. 4 Grant or award Chief Financial Officer acquired 62,718 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
  6. 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
  7. 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
  8. 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
  9. 4 Shares withheld for taxes General Counsel & CLO gave up 3,167 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 3,158 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes Director gave up 175 shares (to pay taxes)
  14. 4 Shares withheld for taxes Director gave up 10,181 shares (to pay taxes)
  15. 4 Shares withheld for taxes Director gave up 10,181 shares (to pay taxes)
  16. 4 Planned sale Director sold 91,911 shares at an average $8.19 ($752,954)
  17. 4 Planned sale Director sold 91,911 shares at an average $8.19 ($752,954)
  18. 4 Planned sale Director sold 95,016 shares at an average $8.88 ($843,864)
  19. 4 Planned sale Director sold 95,016 shares at an average $8.88 ($843,864)
  20. 4 Planned sale Director sold 8,464 shares at an average $7.81 ($66,146)

Page 4 of 7 · 137 filings